Keep oral mucositis
under control with Caphosol^®

EUSA Pharma (USA) inc. announces launch of new Caphosol website

New Caphosol Website offers comprehensive resource on Oral Mucositis and Caphosol^®. EUSA Pharma (USA), Inc. is pleased to have
more...

New CAPHOSOL study shows reduction in severity and duration of Oral Mucositis

A new study of Caphosol^® shows that it diminishes oral mucositis in three key ways: by decreasing severity, lowering peak pain
more...

more news items

Clinical Data

Useful Links

Safety Information

• Reported side effects have been rare and generally mild
• Special precautions for use: Contains sodium (71 mg per 30mL dose). Patients restricted to a low sodium diet should consult their physician before use.
• If Caphosol is swallowed accidentally, no adverse affects are expected
• There are no known interactions with other medicines

For full prescribing information, please click here

Dosing and Administration

Prescribing Information

FAQs